MedTrace Logo

Efficacy and Tolerability of TENS in Endometriosis-related Pain

NCT07393295 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 92

Last updated 2026-03-31

No results posted yet for this study

Summary

ELECTRE is a single-center, randomized, prospective, longitudinal, controlled, two-arm, single-blind study lasting 4 weeks (P1 investigation phase) after a 4-week run-in period.

The study is followed by a 4-week extension phase (P2) in which all participants will be treated with active TENS.

Randomization will be balanced according to a 1:1 ratio.

Conditions

  • Pelvic Pain Associated With Endometriosis or Adenomyosis
  • Pelvic Pain Associated With Refractory Endometriosis
  • Endometriosis

Interventions

DEVICE

Conventional TENS

Every TENS treatment lasts for 45 minutes

DEVICE

Microstimulation TENS

Every TENS treatment lasts for 45 minutes

Sponsors & Collaborators

  • Monath Electronic

    lead INDUSTRY

Principal Investigators

  • Bejamin MERLOT · IFEM Endo, Clinique Tivoli-Ducos, 5 rue Auguste Poirson, 33000 Bordeaux, France

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-03-15
Primary Completion
2027-06-15
Completion
2027-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07393295 on ClinicalTrials.gov